医学
科克伦图书馆
荟萃分析
相对风险
安慰剂
梅德林
围手术期
不利影响
内科学
置信区间
随机对照试验
临床试验
外科
病理
替代医学
法学
政治学
作者
Kurinchi Selvan Gurusamy,Rahul Koti,Giuseppe Fusai,Brian R Davidson
标识
DOI:10.1002/14651858.cd008370.pub3
摘要
Somatostatin analogues may reduce perioperative complications but do not reduce perioperative mortality. Further adequately powered trials with low risk of bias are necessary. Based on the current available evidence, somatostatin and its analogues are recommended for routine use in people undergoing pancreatic resection.
科研通智能强力驱动
Strongly Powered by AbleSci AI